The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 14, 2021
Filed:
Dec. 11, 2017
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Middlesex, GB;
Inventors:
James Francis Callahan, King of Prussia, PA (US);
Roderick S. Davis, King of Prussia, PA (US);
Nicole Cathleen Goodwin, King of Prussia, PA (US);
Jeffrey K. Kerns, King of Prussia, PA (US);
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, Middlesex, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/00 (2006.01); A61K 9/00 (2006.01); C07D 243/08 (2006.01); C07D 281/02 (2006.01); C07D 291/08 (2006.01); C07D 513/04 (2006.01); C07D 515/04 (2006.01); C07D 285/36 (2006.01); C07D 409/14 (2006.01);
U.S. Cl.
CPC ...
C07D 515/04 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/0073 (2013.01); C07D 243/08 (2013.01); C07D 285/36 (2013.01); C07D 291/08 (2013.01); C07D 409/14 (2013.01); C07D 513/04 (2013.01);
Abstract
The present invention relates to bisaryl heterocycle compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to bisaryl heterocycles of Formula (I),